Persistent Bacterial Remnants Identified as Key Driver of Post-Treatment Lyme Disease Syndrome

New research reveals Borrelia burgdorferi peptidoglycan lingers in human tissues, triggering chronic inflammation and opening pathways for targeted therapies.